Ani Pharmaceuticals Inc

ANIPNASDAQ · US

Holders

REDUCEDT+30
Carey Stephen P.
Ani Pharmaceuticals Inc · NASDAQ
−2,850 sh · $208.1K
Filed 30 Sept 2026SEC Form 4view source
REDUCEDT+30
Lalwani Nikhil
Ani Pharmaceuticals Inc · NASDAQ
−5,400 sh · $383.4K
Filed 16 Sept 2026SEC Form 4view source
REDUCEDT+30
Thoma Jeanne
Ani Pharmaceuticals Inc · NASDAQ
−1,000 sh · $71.5K
Filed 14 Sept 2026SEC Form 4view source
REDUCEDT+30
Cook Meredith
Ani Pharmaceuticals Inc · NASDAQ
−500 sh · $35.4K
Filed 14 Sept 2026SEC Form 4view source
REDUCEDStale
Carey Stephen P.
Ani Pharmaceuticals Inc · NASDAQ
−2,850 sh · $207.5K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Gosebruch Henry O
Ani Pharmaceuticals Inc · NASDAQ
+6,662 sh
Filed 27 Aug 2026SEC Form 4view source
REDUCEDStale
Lalwani Nikhil
Ani Pharmaceuticals Inc · NASDAQ
−5,400 sh · $401.2K
Filed 26 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Ani Pharmaceuticals Inc · NASDAQ
96,809 sh · $7.4M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Polen Capital Management
Ani Pharmaceuticals Inc · NASDAQ
6,409 sh · $492.9K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Ani Pharmaceuticals Inc · NASDAQ
186,102 sh · $14.3M
Filed 31 Mar 2026SEC 13Fview source